Clinical Trials in San Francisco

Showing 6141-6160 of 9,883 trials

Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant

NCT02429869

Zortress (everolimus), the 40-O-(2-hydroxyethyl)-derivative of rapamycin, is an mTOR inhibitor approved for rejection prophylaxis in kidney transplant recipients. mTOR inhibition may favorably impact the HIV viral reservoir, and we hypothesize that adding everolimus to the transplant immunosuppressive regimen of HIV positive transplant recipients will decrease HIV persistence in CD4+ lymphocytes.

HIVKidney TransplantLiver Transplant

University of California, San Francisco10 participantsStarted Feb 2016

San Francisco, California, United States

COMPLETEDNA< 1 mile

Yoga During Chemotherapy Study

NCT02442635

This proposal aims to expand non-pharmacologic options for the control of symptoms during chemotherapy using yoga practices. It is particularly focused on sleep disturbance with a secondary focus on fatigue.

CancerSleep DisturbanceFatigue

University of California, San Francisco73 participantsStarted May 2015

San Francisco, California, United States

COMPLETEDNA< 1 mile

Specialized Centers of Research (SCOR)on Sex Differences - Kyphosis Study

NCT01766674

This is a randomized, controlled trial among 100 total males and females with hyperkyphosis, aged 60 years and older, to determine the effects of an exercise intervention that includes high intensity spinal muscle strengthening exercises compared to a usual care waitlist group.

Kyphosis

University of California, San Francisco112 participantsStarted Feb 2013

San Francisco, California, United States

Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant

Yoga During Chemotherapy Study

Specialized Centers of Research (SCOR)on Sex Differences - Kyphosis Study

Find Trials by Condition in San Francisco

Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer

Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)

A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification

Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

Medtronic Minimed Overnight Closed-Loop System

Evaluation of a Non-invasive Brain Compliance Measurement Device

Diabetic Ketoacidosis and Its Impact on the Brain

Comparison Bile Duct Brushings, Cholangioscopy-Directed Biopsies and Pediatric Forceps Biopsies in Biliary Strictures

Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease

The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study